9P Final results from TAIL: Updated long-term safety and efficacy of atezolizumab (atezo) in a diverse population of patients (pts) with previously treated advanced NSCLC

Autor: A. Ardizzoni, S. Azevedo, B. Rubio-Viqueira, D. Rodriguez-Abreu, J. Alatorre-Alexander, H.J.M. Smit, J. Yu, K. Syrigos, E. Hoglander, M. Kaul, J. Tolson, Y. Hu, H.K. Vollan, T. Newsom-Davis
Rok vydání: 2022
Předmět:
Zdroj: Annals of Oncology. 33:S32
ISSN: 0923-7534
DOI: 10.1016/j.annonc.2022.02.018
Databáze: OpenAIRE